XML 30 R15.htm IDEA: XBRL DOCUMENT v3.19.1
STOCK OPTIONS AND WARRANTS
6 Months Ended
Mar. 31, 2019
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
STOCK OPTIONS AND WARRANTS

NOTE G — STOCK OPTIONS AND WARRANTS

 

Warrants

 

The following table summarizes the changes in warrants outstanding. These warrants were granted in lieu of cash compensation for services performed or financing expenses in connection with the sales of the Company’s common stock.

 

Transactions involving warrants (see Note F) are summarized as follows:

 

    Number of 
Shares
    Weighted 
Average 
Exercise 
Price Per 
Share
 
Balance at October 1, 2018     12,208,527     $ 3.24  
Granted     9,035,000       0.48  
Exercised     (1,623,100 )     0.44  
Cancelled or expired     (2,735,000 )     3.00  
Balance at March 31, 2019     16,885,427     $ 2.24  

 

Stock Options

 

In 2005, the Board of Directors and the holders of a majority of the outstanding shares of common stock approved the 2005 Incentive Stock Plan, as amended and restated as of January 21, 2015 (the “Incentive Plan”). The number of shares of common stock that can be issued as stock awards and stock options thereunder is an aggregate of 8,333,333 shares and the number of shares of common stock that can be covered by awards made to any participant in any calendar year is 833,334 shares. The Incentive Plan’s expiration date is January 25, 2025.

 

The Incentive Plan is designed to retain directors, executives, and selected employees and consultants by rewarding them for making contributions to the Company's success with an award of options to purchase shares of common stock. As of March 31, 2019, a total of 275,752 shares have been issued and options to purchase 6,979,095 shares have been granted under the Incentive Plan.

 

Transactions involving stock options issued to employees and consultants are summarized as follows:

 

    Number of 
Shares
    Weighted 
Average 
Exercise 
Price Per 
Share
    Aggregate 
Intrinsic 
Value
    Weighted Average Contractual Life (Years)  
Outstanding at October 1, 2018     6,183,214     $ 3.13                  
Granted     1,578,570       4.48                  
Exercised     -       -                  
Cancelled or expired     (1,303,590 )     (5.63 )                
Outstanding at March 31, 2019     6,458,194     $ 2.95               6.72  
Vested at March 31, 2019     6,338,547     $ 2.96     $ -       6.71  
Non-vested at March 31, 2019     119,647     $ 2.54     $ -          

 

  

The Company uses the Black Scholes Option Pricing Model to determine the fair value of options granted. The following significant weighted average assumptions in the Black Scholes Option Pricing Model were utilized to estimate the fair value of share based payment awards during the six month periods ended March 31, 2019 and 2018:

 

    Six Month Period 
Ended 
March 31, 2019
    Six Month Period 
Ended 
March 31, 2018
 
Stock price   $ 1.14     $ 1.57  
Exercise price   $ 4.47     $ 1.57  
Expected term, years     2.95       4.87  
Dividend yield       -  %     - %
Volatility     77 %     94 %
Risk free rate     2.8 %     2.6 %

 

The Company recorded an expense of $267,094 and benefit of $285,045 as stock compensation for the three month periods ended March 31, 2019 and 2018, respectively which are recorded in selling, general and administrative expenses in the condensed consolidated statement of operations. The Company recorded expense of $757,338 and benefit of $53,932 as stock compensation expense for the six month periods ended March 31, 2019 and 2018, respectively.  As of March 31, 2019, unrecorded compensation cost related to non-vested awards was $144,331, which is expected to be recognized over a weighted average period of approximately 0.79 years. The weighted average grant date fair value per share for options granted during the six month period ended March 31, 2019 was $0.19.